Target intelligence / Profile preview

Human Leukocyte Antigen II (HLA-II)

Target
HLA-II
Molecular classification
Cell surface receptor, Glycoprotein
01

Overview

Human leukocyte antigen class II (HLA-II) molecules are cell-surface glycoproteins encoded by the major histocompatibility complex (MHC) on chromosome 6. They play a central role in the adaptive immune system by presenting processed extracellular antigens to CD4+ T helper cells, thereby initiating and regulating immune responses. They are heterodimers composed of an α and β chain, with the peptide-binding groove formed by the α1 and β1 domains. The main classical HLA class II proteins are HLA-DP, HLA-DQ, and HLA-DR. HLA-II polymorphisms are associated with susceptibility or resistance to autoimmune diseases and transplant compatibility.

Other names
MHC class IIMajor Histocompatibility Complex class II
02

Mechanism of action

N/A

03

Biological functions

Antigen presentationT cell activationAdaptive immune responseImmune regulation
04

Disease associations

Autoimmune diseasesTransplant rejectionInfectious diseasesInflammatory diseases
05

Safety considerations

Off-target effects of immunomodulatory therapiesRisk of graft-versus-host disease (GVHD) in transplantation
06

Biomarkers

HLA-DR alleles (e.g., DRB1*0401 for rheumatoid arthritis)HLA-DQ alleles (e.g., DQA1*0501/DQB1*0201 for type 1 diabetes)

Beyond the preview

Go deeper on Human Leukocyte Antigen II (HLA-II).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human Leukocyte Antigen II (HLA-II).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call